DocMorris FCF Conversion
The FCF Conversion Rate (FCF/EBITDA) of DocMorris (DOCM.SW) as of Jul 26, 2026 is 66.99 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 56.77 % — a change of 18.01% (higher).
Get this data via API
Financial Data API
FCF Conversion
66.99 %
YoY
18.01%
Last updated:
FCF Conversion Rate (FCF/EBITDA) of DocMorris is 2026 66.99 % . FCF Conversion Rate (FCF/EBITDA) of DocMorris was 2025 56.77 % . It decreases by 18.01% higher compared to the previous year.
Access this data via the Eulerpool API
DocMorris Stock analysis
What does DocMorris do? The Zur Rose Group AG is a Swiss company that specializes in online trading of medications and health products. The company was founded in 1993 in Steckborn and initially focused on the mail order of homeopathic medicines. In 1997, the online shop www.zurrose.de was opened and the company began to expand its distribution to non-homeopathic medicines.
The business model of the Zur Rose Group AG is based on a three-pillar model, encompassing e-commerce, wholesale, and healthcare. In the e-commerce sector, the company operates online pharmacies in various countries including Germany, France, Austria, the Netherlands, and Switzerland. In the wholesale sector, the company supplies pharmacies and hospitals with medicines and medical products. In the healthcare sector, the company offers various services in healthcare, from the production of medicines to the processing of prescriptions.
The Zur Rose Group AG offers a wide range of products and services including prescription and over-the-counter medications, natural remedies, cosmetic products, dietary supplements, and medical devices. The company aims to provide its customers with a comprehensive selection of high-quality products and works closely with its suppliers to ensure that all products meet the highest quality standards.
In the e-commerce sector, the company operates various online pharmacies, including Zur Rose Apotheke in Germany, Zur Rose Apotheke in Austria, and Doctipharma in France. These online pharmacies offer a wide range of medications and health products that can be ordered online and conveniently delivered to customers' homes. The online pharmacies are open 24/7, allowing customers to quickly and easily order their needed medications.
In the wholesale sector, the company offers a wide range of pharmaceutical products and medical devices to pharmacies and hospitals. The company works closely with its suppliers to ensure that all products meet the highest quality standards. Additionally, the company also provides a fast and reliable delivery service to ensure that its customers are always provided with the needed medications and medical products.
In the healthcare sector, the company offers various services in healthcare, including digitalization solutions for pharmacies, manufacturing of medications, and processing of prescriptions. The company works closely with its customers to offer tailored solutions that meet their individual requirements.
Over the years, the Zur Rose Group AG has become a leading provider in the online trading of medications and health products. The company has distinguished itself through its wide product range, fast and reliable delivery service, and excellent customer service. Additionally, the company has also invested in the development of new technologies to ensure that it can always offer its customers the best products and services.
Overall, the Zur Rose Group AG is an innovative company built on a long history in healthcare. The company strives to offer its customers a wide range of high-quality products and services and has established itself as a leading provider in the online trading of medications and health products. DocMorris is one of the most popular companies on Eulerpool.
Frequently Asked Questions about DocMorris stock
FCF Conversion Rate (FCF/EBITDA) of DocMorris is 66.99 % in 2026.
Access this data via the Eulerpool API
Cash Flow — DocMorris
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — DocMorris
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth